Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study
- PMID: 31842811
- PMCID: PMC6915922
- DOI: 10.1186/s12885-019-6423-5
Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study
Abstract
Background: The posterior-inferior border of symphysis (PIBS) point system is a novel vaginal dose-reporting method and is a simple and reliable method proposed by the Medical University of Vienna proposed for both external-beam radiotherapy (EBRT) and brachytherapy (BT). In this multicenter study, we sought to first evaluate the vaginal radiation dose in Chinese cervical cancer patients according to the PIBS point system and then to analyze the factors influencing the dose distribution.
Methods: We collected data from the medical records of 936 cervical cancer patients who underwent concurrent radiochemotherapy at 13 different institutions in China. Radiation doses at points A, PIBS+ 2 cm, PIBS and PIBS-2 cm, International Commission on Radiation Units (ICRU)-R and ICRU-B were measured.
Results: The median total doses in EQD2α/β = 3 at points PIBS+ 2 cm, PIBS and PIBS-2 cm were 82.5 (52.7-392.1) Gy, 56.2 (51.4-82.1) Gy and 2.6 (0.9-7.4) Gy, respectively. The median total doses in EQD2α/β = 3 at ICRU-R and ICRU-B were 77.5 (54.8-132.4) Gy and 79.9 (60.7-133.7) Gy, respectively. The mean vaginal reference length (VRL) was 4.6 ± 1.0 cm (median, 4.5 cm). In patients with VRL ≤4.5 cm, the mean total doses in EQD2α/β = 3 at points PIBS+ 2 cm, PIBS and PIBS-2 cm were 128.5, 60.7 and 0.8 Gy, respectively. In patients with VRL > 4.5 cm, the mean total doses at these three points were 68.9, 0.5 and 54.5 Gy, respectively. Classification of patients revealed significant differences (P < 0.05) between these two groups.
Conclusions: With the PIBS point system, Chinese patients with a shorter VRL of < 4.5 cm received higher radiation doses at the PIBS+ 2 cm, PIBS and PIBS-2 cm points than European and American patients. Further studies are required to establish the dose-effect relationships with these points as references. The study was registered as a clinical trial (NCT03257475) on August 22, 2017.
Keywords: Cervical cancer; PIBS; Radiotherapy; Vaginal dose.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Using New Vaginal Doses Evaluation System to Assess the Dose-Effect Relationship for Vaginal Stenosis After Definitive Radio(Chemo)Therapy for Cervical Cancer.Front Oncol. 2022 Apr 19;12:840144. doi: 10.3389/fonc.2022.840144. eCollection 2022. Front Oncol. 2022. PMID: 35515128 Free PMC article.
-
Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy.Phys Med. 2019 Mar;59:127-132. doi: 10.1016/j.ejmp.2019.01.017. Epub 2019 Feb 13. Phys Med. 2019. PMID: 30772142
-
Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.Radiother Oncol. 2022 Mar;168:8-15. doi: 10.1016/j.radonc.2021.12.034. Epub 2022 Jan 19. Radiother Oncol. 2022. PMID: 35063582
-
Vaginal dose assessment in image-guided brachytherapy for cervical cancer: Can we really rely on dose-point evaluation?Brachytherapy. 2016 Mar-Apr;15(2):169-76. doi: 10.1016/j.brachy.2015.11.005. Epub 2016 Jan 5. Brachytherapy. 2016. PMID: 26778755
-
Quality Assurance in Clinical Trials Requiring Radiation Therapy in Sub-Saharan Africa.Int J Radiat Oncol Biol Phys. 2023 Jun 1;116(2):439-447. doi: 10.1016/j.ijrobp.2022.11.042. Epub 2022 Dec 7. Int J Radiat Oncol Biol Phys. 2023. PMID: 36493958 Free PMC article. Review.
Cited by
-
Using New Vaginal Doses Evaluation System to Assess the Dose-Effect Relationship for Vaginal Stenosis After Definitive Radio(Chemo)Therapy for Cervical Cancer.Front Oncol. 2022 Apr 19;12:840144. doi: 10.3389/fonc.2022.840144. eCollection 2022. Front Oncol. 2022. PMID: 35515128 Free PMC article.
References
-
- Zhang KS, Liu Z, Wang T, Wang J, Su J, Shi F, et al. Occurrence of radiation-induced injury in vagina after radical radiotherapy of cervical cancer and its affecting factors. Zhonghua Fu Chan Ke Za Zhi. 2018;53(4):257–262. - PubMed
-
- Kirchheiner K, Nout RA, Lindegaard JC. Haie-Meder, Mahantshetty U, Segedin B, et al. dose-effect relationship and risk factors for vaginal stenosis after definitive radio (chemo) therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study. Radiother Oncol. 2016;118(1):160–166. doi: 10.1016/j.radonc.2015.12.025. - DOI - PubMed